Cheryl Lai, Acting Deputy Editor of The Lancet Oncology, is joined by Professor Fred Saad (Department of Surgery/Urology, University of Montreal, Montreal, QC, Canada) to discuss pain and health-related quality-of-life outcomes from the randomised phase 3 ARANOTE trial of darolutamide in metastatic hormone-sensitive prostate cancer. Hear about the findings f ... Show More
Mar 30
James Nagarajah on [177Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 study
Cheryl Reeves, Senior Editor at The Lancet Oncology, is joined by Professor James Nagarajah to discuss his open-label, randomised, phase 2 study [177Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE). Click here to read the full article: https:/ ... Show More
10m 55s
Mar 9
Kayleigh Bhangdia on breast cancer GBD study 2023
Kayleigh Bhangdia discusses the latest GBD breast cancer study data, telling the audience about epidemiological trends, disease burden, and risk factors associated with breast cancer globally, regionally, and nationally for 204 countries from 1990 to 2023. Kayleigh sheds light on ... Show More
18m 23s
Jun 2024
Cancer Prevention with Dr. Leigh Erin Connealy, MD
<p>Today I am speaking with <strong>Dr. Leigh Erin Connealy, MD. Dr. Connealy is </strong>absolutely<strong> </strong>amazing, and I was so interested to have her on the podcast because of her incredible experience and philosophy on cancer prevention. </p>
<p>We discuss cancer ra ... Show More
1h 3m
Mar 2025
Dr. Patrick Soon-Shiong: You’re Being Lied to About Cancer, How It’s Caused, and How to Stop It
Dr. Patrick Soon-Shiong is a surgeon who made billions inventing cancer drugs. He says that Covid, and the vaccines that didn’t stop it, are likely causing a global epidemic of terrifyingly aggressive cancers.
(00:00) Why Are Cancer Rates Rising in Young People?
(06:16) What Is ... Show More
1h 52m